Objectives-To examine the immunohistological features in the involved skin of patients with psoriatic arthritis (PA) (n = 15), compared with those in involved skin from patients with psoriasis but no arthritis (n = 5), and with a group with normal skin (n = 4), to identify markers for arthritis in psoriasis. Methods-Skin was obtained from patients by 6 mm punch biopsy and normal skin was provided by the department of plastic surgery. Samples were stained with monoclonal antibodies against T cells (CD3, CD8, CD4, CD45Ro), B cells (CD20), macrophages (mac387), vascular endothelium (FVIIIrelated antigen) and a Langerhan's cell marker (pl55). The number of cells/ vessels staining with each monoclonal antibody was calculated and serial sections of skin were examined to estimate the presence of DR +keratinocytes. Results-There were significantly more CD45Ro T-cells and blood vessels in patients with psoriatic arthritis compared with both psoriasis alone, and with normal controls (p<002). While B-cells were not seen in psoriasis without arthritis or in normal skin, a small but significant number were observed in PA (p<002). Furthermore, while DR + keratinocytes were present in both psoriatic arthritis and psoriasis skin, there were significantly more DR + cells in the psoriatic arthritis epidermis compared with psoriasis alone (p<002).
(p<002).
Conclusions-This study suggests that increased numbers of CD45Ro T-cells, greater vascularity, the presence of B-cells, and increased numbers of DR + epidermal cells are markers for arthritis in patients with sporiasis.
(Ann Rheum Dis 1994; 53: 450-454) Psoriasis (Ps) is a common, chronic, inflammatory skin disorder which affects 2-3% of the population in Northern Europe.' A subgroup of between 5-7%/o of these patients will have an associated inflammatory arthritis.23
The reasons for this are not clear and indeed it is not possible to predict which patients will develop an arthritis.
Immunohistological studies in Ps have demonstrated a number of characteristic findings: inflammatory cells, predominantly T lymphocytes, accumulate in the skin,4-6 there are prominent microvascular changes7 8 and keratinocytes (KCs) become highly activated.9'-" The activated T lymphocyte expresses the antigen CD45Ro+, the class II MHC antigen HIA-DR+ and receptors all of which are important molecules in the recognition and binding of antigen peptide.'2 Cell surface markers, including adhesion molecules such as intercellular *adhesion molecule (ICAM-1), play important roles in cell-cell recognition, binding and communication necessary in the immune response. '3 In contrast to the previously perceived role of KCs as being uninvolved in the inflammatory process, it is now known that they produce a number ofproinflammatory cytokines and that they may express both MHC class II HLA-DR antigens as well as ICAM-1.1°" Furthermore, it has been suggested that the presence of HIA-DR+ keratinocytes may be a marker for arthritis in psoriasis. 14 In this study, a quantitative immunohistological examination of the involved skin from patients with psoriatic arthritis (PA) was undertaken. Results were compared with skin obtained from patients with psoriasis but no arthritis (Ps) and with normal control skin to identify markers for arthritis in psoriasis.
Materials and methods

PATIENT POPULATION
Patients with Ps and PA were recruited from outpatient clinics and as inpatients from the wards of the dermatology and the rheumatology services of the City of Dublin Skin and Cancer Hospital, Beaumont Hospital and St Vincent's Hospital, Dublin. This ensured that patients with a spectrum of mild to severe skin and joint disease were included in the study. Patients were required to satisfy the criteria of Moll and Wright for the diagnosis of PA;'5 however, patients with a rheumatoid factor titre greater than 1:80 were excluded from the study. Patients who had taken diseasemodifying antirheumatic drugs or undergone psoriasis therapy within the three months before assessment were excluded. All patients gave their informed consent, and the study had the approval of the Ethics Committees of all three hospitals.
Skin biopsies were obtained from 15 patients with PA. There were eight females and the mean (range) age was 50 years . The mean (range) disease duration of psoriasis was 15 years (0-25-50) and of arthritis was seven years (0-25-24). All patients had psoriasis vulgaris, eight had an asymmetric oligoarthritis and seven had a symmetrical polyarthritis. Skin biopsies were also obtained from five patients with psoriasis but no arthritis (Ps) and from four normal control subjects. Extent and severity of psoriasis was evaluated in the percentage of skin involved using the rule of 9s. The median (range) in the PA group was 18% (9-72) and in the Ps group was 18% (9-63) demonstrating that no significant difference existed in the skin disease between the two groups. Skin biopsies were obtained before the start of treatment of the skin disease. CLINICAL 
ASSESSMENT
All patients were assessed by the same physician (DV). A full history was taken including previous therapy as an outpatient ( Furthermore, in a subgroup of patients in which serial sections of skin were examined, HLA-DR+ keratinocytes were identified in the epidermis of psoriasis patients with or without arthritis. Finally, the number of dermal blood vessels was significantly increased in both PA and Ps patients compared with controls. The finding of a sparse B cell infiltrate with some plasma cells in PA skin is interesting. Psoriasis is not generally associated with B cell hyperactivity although autoantibody production has been reported. '8 19 Indeed T cells, predominantly T helper (CD4+) cells, have previously been described to represent the majority of the cells in the dermal infiltrate in pS4 14 and may persist in the chronic psoriatic plaque.6 Many T cells in psoriatic skin express the class II HIA-DR antigen and these cells have been shown to increase in the dermis and infiltrate the epidermis during early development of a psoriatic lesion.5 Further evidence for T cell involvement in the pathogenesis of psoriasis is suggested by the observations that cyclosporin A, a drug which inhibits T cell activation, may lead to remission of the skin disease2' and clearance of severe psoriasis has been described after allogenic bone marrow transplantation.22 In the present study, the findings confirm previous reports of a predominant T cell infiltrate, these cells expressing the HLA-DR and CD45Ro antigens indicating that they are memory T Vascular abnormalities have been described in both the skin and synovium in psoriasis. Braverman extensively examined the microcirculation in psoriatic skin and described prolongation and dilatation of the dermal capillary loops.7 In addition, ultrastructural abnormalities in the blood vessels were seen on electron microscopy with the development of venous-like capillaries with bridged fenestrations.' Similar changes in vascularity have been described in the synovial membrane in PA.28 These studies, however have not been quantitative and a comparison of the vascularity of PA and Ps skin has not been previously undertaken. In this study, psoriatic skin is shown to be more vascular compared with control specimens with a trend towards more blood vessels in the skin from PA subjects compared with those with psoriasis alone.
In conclusion, the present study has iden- 
